1.Correlations of immune cell infiltration characteristics with clinicopathological parameters in patients with clear cell renal cell carcinoma.
Huaxuan ZHAO ; Guichao ZHANG ; Jiarong LIU ; Futian MO ; Taoen LI ; Chengyong LEI ; Shidong LÜ
Journal of Southern Medical University 2025;45(6):1280-1288
OBJECTIVES:
To investigate the characteristics of immune cell infiltration in tumor samples from Chinese patients with clear cell renal cell carcinoma (ccRCC) and the correlation of immune cell infiltration with tumor stage and response to immunotherapy.
METHODS:
Tumor samples and clinicopathological data were collected from 154 ccRCC patients treated in Nanfang Hospital, Southern Medical University from October, 2020 to October, 2023. The immune cell types infiltrating the tumor tissues were identified using immunohistochemistry and immunofluorescence staining, and their correlations with the patients' clinicopathological characteristics were analyzed. Patient-derived tumor tissue fragment models (PDTF) models, constructed using tumor tissues from 22 patients, were treated with PD-1 monoclonal antibody, and T cell activation was detected using flow cytometry to assess the patients' responses to immunotherapy.
RESULTS:
In Chinese ccRCC patients included in this study, CD8+ T cells, CD4+ T cells, and CD3+ T cells were the most abundant in the tumor tissues. Higher infiltration levels of CD3+ T cells (P=0.004), PD-1+ T cells (P=0.020), CD68+ T cells (P=0.049), CD79+ T cells (P=0.049), and Tryptase+ cells (P=0.049) were all positively correlated with a larger tumor size (≥5 cm). A higher infiltration level of CD4+ T cells was associated with a lower tumor stage. Patients with higher International Society of Urological Pathology (ISUP) grades had higher infiltration levels of CD3+ T cells (P=0.023), CD8+ T cells (P=0.045), PD-1+ T cells (P=0.014), CD20+ B cells (P=0.020) and CD79+ B cells (P=0.049), and lower levels of Tryptase+ cells (P=0.001). Patients with abundant infiltrating immune cells tended to have better responses to immunotherapy.
CONCLUSIONS
The infiltrating immune cells are heterogeneous in Chinese ccRCC patients, and immune cell infiltration characteristics are closely correlated with clinicopathological parameters of the patients.
Humans
;
Carcinoma, Renal Cell/pathology*
;
Kidney Neoplasms/pathology*
;
Immunotherapy
;
Male
;
Lymphocytes, Tumor-Infiltrating/immunology*
;
Female
;
Middle Aged
;
CD8-Positive T-Lymphocytes/immunology*
;
Aged
;
T-Lymphocytes/immunology*
;
Programmed Cell Death 1 Receptor/immunology*
;
Adult
;
CD4-Positive T-Lymphocytes/immunology*
;
Neoplasm Staging
2.Ergonomics methodology,application framework and research prospect for unmanned aerial vehicle lifecycle
Shihui ZHANG ; Guichao SHI ; Chuanyan FENG ; Kun JI
Space Medicine & Medical Engineering 2024;35(3):180-186
With the rapid growth of the utilization of Unmanned Aerial Vehicle(UAV),the corresponding ergonomics problems are becoming increasingly prominent.Based on a review of the literature and industrial practice,ergonomics evaluation methods for UAV lifecycle are investigated in this study.The ergonomics research scope of UAV and the ergonomics evaluation method of UAV lifecycle are emphasized;The ergonomics analysis framework of UAV lifecycle is proposed,and the ergonomics practice method under key lifecycle stage of UAV development for typical applications is explained;In addition,combined with the development of intelligent technology,the research prospect of ergonomics on UAV is put forward.This study can provide some reference for the development of UAV from the perspective of ergonomics design and evaluation.
3.The investigation and prognosis in patients with non-alcoholic fatty liver disease and coronary vulnerable plaque
Xiaoyan YANG ; Yi JIAN ; Yuquan ZHONG ; Kang WANG ; Dezhi LIN ; Guichao TANG ; Xu ZHANG
Chinese Journal of Internal Medicine 2020;59(8):623-628
Objective:To investigate the prevalence and prognosis of non-alcoholic fatty liver disease (NAFLD) complicated with coronary vulnerable plaque (VP).Method:Consecutive patients were included who had undergone coronary artery CT angiography (CCTA) from January 1, 2011 to January 30, 2015 at the First People′s Hospital of Neijiang. NAFLD was diagnosed according to the liver imaging findings (liver/spleen CT ratio≤1.0) and clinical data. Baseline data, diagnosis, vulnerable plaque were recorded and followed up. The end points included all-cause death rate, cardiac death rate, non-fatal myocardial infarction rate, and elective coronary revascularization rate.Result:A total of 1 069 patients were eventually recruited in this study, including 316 (29.6%) cases diagnosed as NAFLD. In patients with NAFLD, 130 (41.1%) cases had vulnerable plaque, which was significantly higher than 217 of 753 non-NAFLD patients (28.8%) ( P<0.01). The percentages of spotty calcification, low attenuation plaque, positive remodeling and napkin ring sign in NAFLD cohort were 36.5%, 14.2%, 17.6% and 6.8% respectively, while those corresponding in non-NAFLD cohort were 18.4%, 6.3%, 5.8% and 3.2% respectively. The proportion of each vulnerable feature in NAFLD cohort was significantly higher than that in the non-NAFLD cohort, with P values of 0.016, 0.028, 0.019 and 0.042, respectively. The cardiac mortality rate in NAFLD group was significantly higher than and that of non-NAFLD group (7.0% vs. 3.6%, P=0.044). Multivariate Cox analysis suggested that NAFLD was not an independent risk factor for cardiac death. NAFLD subgroup ( n=316) was divided into VP positive group (NAFLD+VP+, n=130) and VP negative group (NAFLD+VP-, n=186). The mean follow-up time was 4.6±1.3 years. All-cause mortality rate, cardiac death rate, elective coronary artery reconstruction rate, non-fatal myocardial infarction rate in NAFLD+VP+group were 20.8%, 12.3%, 25.4%, 13.8% respectively, which were significantly higher than those corresponding rates in NAFLD+VP-group (5.9%, 3.2%, 8.6%, 6.5%) ( P<0.01, 0.002,<0.01, and 0.032 respectively). Conclusion:The incidences of cardiac mortality, elective coronary revascularization, and non-fatal myocardial infarction are significantly higher in patients with NAFLD than those without. NAFLD combined with vulnerable plaque of coronary arteries predicts worse prognosis.
4.Comparasion of shear wave elastography and 18F-FDG PET/CT imaging in diagnosis of thyroid microcarcinoma
Lichun ZHENG ; Xiangliu OUYANG ; Guichao LIU ; Yueming HU ; Yanbin WANG ; Xiaoming ZHANG
Chinese Journal of Medical Imaging Technology 2017;33(6):868-871
Objective To compare the diagnostic value of shear wave elastography and 18F-FDG PET/CT imaging in diagnosis of thyroid microcarcinoma.Methods Shear wave elastography and 18F-FDG PET/CT data of patients with thyroid nodules confirmed by pathology were analyzed retrospectively.The sensitivity,specificity,accuracy,positive and negative predictive value of the two methods in diagnosis of malignant thyroid micronodules were compared.Results In all of the 48 micronodules,37 were malignant,11 were benign.The sensitivity,specificity,accuracy,positive predictive value and negative predictive value of shear wave elastography and 18F-FDG PET/CT were 91.89% (34/37),81.82% (9/11),89.58% (43/48),94.44% (34/36),75.00% (9/12) and 29.73% (11/37),72.73% (8/11),39.58% (19/48),78.57% (11/ 14),23.53% (8/34),respectively.The sensitivity,accuracy and negative predictive value between the two methods had statistical difference (all P<0.05),and the specificity and positive predictive value between the two methods had no statistical difference (both P>0.05).Conclusion Compared to 18F FDG PET/CT imaging,the diagnositic value of shear wave elastography in diagnosis of thyroid microcarcinoma has obvious advantages.
5.Research progress in molecular classification of gastric cancer.
Menglong ZHOU ; Guichao LI ; Zhen ZHANG
Chinese Journal of Gastrointestinal Surgery 2016;19(9):1072-1076
Gastric cancer(GC) is a highly heterogeneous malignancy. The present widely used histopathological classifications have gradually failed to meet the needs of individualized diagnosis and treatment. Development of technologies such as microarray and next-generation sequencing (NGS) has allowed GC to be studied at the molecular level. Mechanisms about tumorigenesis and progression of GC can be elucidated in the aspects of gene mutations, chromosomal alterations, transcriptional and epigenetic changes, on the basis of which GC can be divided into several subtypes. The classifications of Tan's, Lei's, TCGA and ACRG are relatively comprehensive. Especially the TCGA and ACRG classifications have large sample size and abundant molecular profiling data, thus, the genomic characteristics of GC can be depicted more accurately. However, significant differences between both classifications still exist so that they cannot be substituted for each other. So far there is no widely accepted molecular classification of GC. Compared with TCGA classification, ACRG system may have more clinical significance in Chinese GC patients since the samples are mostly from Asian population and show better association with prognosis. The molecular classification of GC may provide the theoretical and experimental basis for early diagnosis, therapeutic efficacy prediction and treatment stratification while their clinical application is still limited. Future work should involve the application of molecular classifications in the clinical settings for improving the medical management of GC.
Asian Continental Ancestry Group
;
Carcinogenesis
;
genetics
;
Disease Progression
;
Early Detection of Cancer
;
Epigenesis, Genetic
;
physiology
;
High-Throughput Nucleotide Sequencing
;
Humans
;
Microarray Analysis
;
Molecular Epidemiology
;
standards
;
Mutation
;
physiology
;
Prognosis
;
Stomach Neoplasms
;
classification
;
genetics
6.Application of radiomics approach for decoding normal liver features and predicting chemotherapy-associated liver injury:A preliminary study
Fan XIA ; Panpan HU ; Jiazhou WANG ; Weigang HU ; Guichao LI ; Zhen ZHANG
China Oncology 2016;26(6):521-526
Background and purpose:Radiomics refers to the comprehensive quantification of human tissues through assessing a large number of quantitative image features. Radiomics approach is used to decode tumor phenotypes and predict treatment outcomes. Here we present a study investigating radiomic analysis to assess normal liver features and predict chemotherapy-associated liver injury.Methods:Gastric cancer patients treated with surgery and adjuvant chemotherapy were enrolled in this study retrospectively. CT images were obtained before chemotherapy. The whole liver organ was delineated by radiation oncologists. Images were extracted and filtered by radiomic approach to extract radiomic features. Clustering was performed to reveal clusters of patients with similar radiomic expression patterns. Chi-squared tests were used to assess the association of radiomic data with clinical data and chemotherapy-related liver injury.Results:Radiomic features of 73 patients were clustered into two clusters. A significant association with gender (P=0.004, chi-squared test) was observed, where in male showed a higher presence in cluster Ⅰ. Incidence of abnormal liver function after chemotherapy was 48.7% in cluster I and 67.6% in cluster Ⅱ, respectively (Δ=18.9%). Clinical data including age, gender, chemotherapy modality, number of chemotherapy cycles, HBV infection history, HBs-antigen presence were not associated with liver function abnormalities after chemotherapy. Accuracy of radiomic analysis to predict liver injury is 0.59.Conclusion:Radiomic approach revealed different imaging features of liver between men and women. It could help to predict chemotherapy-associated liver injury. It is feasible to use radiomics approach to decode normal liver features and predict treatment-associated liver injury.
7.Research progress of radiotherapy and molecular classifications of gastric cancer
Menglong ZHOU ; Yaqi WANG ; Guichao LI ; Zhen ZHANG
Journal of Chinese Physician 2016;18(5):659-663
Adjuvant radiotherapy (RT) can improve the rate of loco-regional control for patients with gastric cancer (GC),while the selection of patients plays a key role.As the research moves along,several relatively comprehensive molecular classifications emerged such as the TCGA classification and the ACRG classification.Studies have demonstrated that molecular classifications are closely related to the clinicopathologic characteristics,prognosis and treatment response.However,there is not recognized molecular classification of GC presently.It is a great challenge for radiation oncologists to make use of the individual bioinformation and accurately select patients who would benefit from RT.Meanwhile,precision RT could also be achieved with the prediction of radiosensitivity,combination of RT with targeted therapy and the application of ctDNA within the field of RT.
8.Prediction of efficacy of neoadjuvant radiochemotherapy based on depth of invasion in T3 rectal cancer.
Lijun SHEN ; Tong TONG ; Hui ZHANG ; Yiqun SUN ; Ji ZHU ; Gang CAI ; Guichao LI ; Liping LIANG ; Xin CAI ; Ming FAN ; Jiaying HUANG ; Lifeng YANG ; Wenjie SUN ; Sanjun CAI ; Zhen ZHANG
Chinese Journal of Gastrointestinal Surgery 2014;17(6):551-555
OBJECTIVETo investigate the association of mesorectal invasion depth before neoadjuvant radiochemotherapy with pathological outcome and to provide evidence for individualized treatment in T3 rectal cancer.
METHODSRetrospective analysis was performed on the clinical records of 73 consecutive rectal cancer patients treated with neoadjuvant radiochemotherapy and radical surgery in the Shanghai Cancer Center from January 2010 to December 2012. All the patients underwent high-resolution MRI and the depth of mesorectal invasion, lymph node status, tumor length, and mesorectal fascia status were evaluated. The category T3 was subdivided according to the measurement of the maximal tumor invasion beyond the outer border of the muscularis propria: T3a(<5 mm), T3b(5-10 mm) and T3c(>10 mm). The association of mesorectal invasion depth,other MRI and clinical features with short-term efficacy was analyzed,especially with pathological complete response(pCR).
RESULTST3a, T3b and T3c accounted for 19.2%, 64.4% and 16.4% in 73 rectal cancer patients who underwent high resolution MRI, respectively. There were 42.9% of T3a patients achieved pathological complete response,significantly higher than those of T3b(14.9%)and T3c(0%) (P=0.017).
CONCLUSIONST3a rectal cancer patients are more likely to achieve pCR than those of T3b and T3c after neoadjuvant radiochemotherapy. The maximal tumor invasion beyond the outer border of the muscularis propria less than 5 mm may act as a predictive factor and guide the follow-up treatment of T3 rectal cancer.
Adult ; Aged ; Chemoradiotherapy ; Female ; Humans ; Male ; Middle Aged ; Neoadjuvant Therapy ; Neoplasm Invasiveness ; Rectal Neoplasms ; pathology ; therapy ; Retrospective Studies ; Treatment Outcome ; Young Adult
9.Prediction of efficacy of neoadjuvant radiochemotherapy based on depth of invasion in T3 rectal cancer
Lijun SHEN ; Tong TONG ; Hui ZHANG ; Yiqun SUN ; Ji ZHU ; Gang CAI ; Guichao LI ; Liping LIANG ; Xin CAI ; Ming FAN ; Jiaying HUANG ; Lifeng YANG ; Wenjie SUN ; Sanjun CAI ; Zhen ZHANG
Chinese Journal of Gastrointestinal Surgery 2014;(6):551-555
rectal cancer patients are more likely to achieve pCR than those of T3b and T3c after neoadjuvant radiochemotherapy. The maximal tumor invasion beyond the outer border of the muscularis propria less than 5 mm may act as a predictive factor and guide the follow-up treatment of T3 rectal cancer.
10.Prediction of efficacy of neoadjuvant radiochemotherapy based on depth of invasion in T3 rectal cancer
Lijun SHEN ; Tong TONG ; Hui ZHANG ; Yiqun SUN ; Ji ZHU ; Gang CAI ; Guichao LI ; Liping LIANG ; Xin CAI ; Ming FAN ; Jiaying HUANG ; Lifeng YANG ; Wenjie SUN ; Sanjun CAI ; Zhen ZHANG
Chinese Journal of Gastrointestinal Surgery 2014;(6):551-555
rectal cancer patients are more likely to achieve pCR than those of T3b and T3c after neoadjuvant radiochemotherapy. The maximal tumor invasion beyond the outer border of the muscularis propria less than 5 mm may act as a predictive factor and guide the follow-up treatment of T3 rectal cancer.

Result Analysis
Print
Save
E-mail